OCRA is leading the field of ovarian cancer research.

We invest our dollars wisely – $110 million to date – supporting the best ovarian cancer research in the nation.

Every day, OCRA-funded scientists are improving lives by finding new ways to prevent ovarian cancer, developing better methods to treat it, and pioneering pathways to cure this disease. OCRA-funded projects have led to significant advances in such areas as early detection, diagnosis, genetics, prevention, treatments, and enhancing quality of life.

In 2021, OCRA-funded researchers made major breakthroughs in the fight against ovarian cancer:

Read about our OCRA Grantees’ discoveries in 2020 →

The results of OCRA-supported research projects have been published in some of the world’s most prestigious journals, such as: Gynecologic Oncology, Lancet Oncology, New England Journal of Medicine, Cancer Research, Clinical Cancer Research, Cell Reports, Journal of Clinical Oncology, Molecular Cancer Research, Cell, Science Translational Medicine, Cancer Discovery and Nature.